Background Knowledge of the sequences of mycobacterial genes and the availability of DNA amplification techniques have raised the possibility that identification of mycobacterial DNA may offer a rapid and specific diagnostic test for tuberculosis. The correlation between the presence of Mycobacterium tuberculosis DNA and clinical tuberculosis, however, is not known. This study compared the results of polymerase chain reaction amplification of two M tuberculosis DNA sequences, IS6110 and the gene encoding the 65kDa heat shock protein (65kDa Ag), from sputum, bronchoscopy washings, and bronchoalveolar lavage fluid and related these findings to the presence of active and past tuberculosis. Methods Highly specific primers were used for amplification ofIS61 10 and 65kDa Ag DNA. Analysis was performed on one or more samples from 87 patients.
non-tuberculous lung diseases. Conclusion These data suggest that the presence of IS6110 DNA correlates more closely with a tuberculosis related diagnosis than that of 65kDa Ag DNA and that both DNAs are found in most subjects with past tuberculosis or contacts of patients with tuberculosis. This may limit the clinical usefulness of these tests.
radioactive carbon (14C) released from the metabolised fatty acids in the medium and accelerates the time to diagnosis, but it may still take one to two weeks.
Amplification ofspecific mycobacterial DNA by polymerase chain reaction (PCR) offers the possibility of a rapid, sensitive, and specific test for tuberculosis. This technique raises interesting possibilities, including the ability to analyse a range of samples including cerebrospinal fluid and blood to diagnose tuberculosis, the study of subtle genomic differences in mycobacteria to explain the epidemiology of tuberculosis, and rapid identification of mycobacteria in immunocompromised patients.
Two of the many mycobacterial DNA sequences are candidates for a diagnostic test. These are the gene encoding the 65kDa heat shock protein (65kDa Ag)' and the sequence of IS6110, a mycobacterium specific DNA sequence present as repeats in the genome.37 Studies using probes for the 65kDa Ag gene and probes combined with DNA amplification have succeeded in identifying mycobacteria obtained after routine culture, [8] [9] [10] [11] [12] and from Bactec culture. '3 " Combined amplification and probing has also been used successfully in preliminary studies on clinical samples from patients with tuberculosis.'" 16 The relation between the bacteriological identification ofMycobacterium tuberculosis and clinical disease is well recognised. Detection 
presence ofmycobacterial DNA was confirmed by autoradiography with exposures of 2-24 hours.
All experiments included positive control samples where mycobacterial DNA was included and negative control samples where sample DNA was omitted.
Results

IDENTIFICATION OF IS61 10 AND 65KDA AG DNA IN SPUTUM FROM PATIENTS WITH TUBERCULOSIS
In initial studies, IS6110 DNA was detected in sputum from patients with tuberculosis but not from patients with other lung diseases by both ethidium bromide staining and subsequent probing with 32p labelled IS3. Similarly, amplification of 65kDa Ag DNA and subsequent probing with 32p labelled TB4 oligonucleotide identified the 65kDa Ag DNA in sputum from a patient with tuberculosis, while sputum from a patient with small cell lung cancer contained no 65kDa Ag DNA.
REQUIREMENT FOR 32p PROBING To determine whether ethidium bromide staining and 32p probing were required to identify IS6110, the results in 55 patients were compared. Fourteen cases were positive by both indicators and 41 negative by both systems. No cases were positive on one detection system only, so ethidium bromide staining was used alone to identify IS6110 DNA in subsequent clinical samples. When ethidium bromide staining and 32P probing were compared for the 65kDa Ag DNA, 11 cases were identified by both ethidium bromide and 32p TB4 and eight by 32P TB4 alone. 32p probing was used to confirm the presence of 65kDa Ag DNA in subsequent clinical samples. Ninety respiratory samples-from sputum, bronchoscopy trap, and bronchoalveolar lavage-were collected from 87 patients. Several samples were obtained from seven patients, and three patients gave more than one type of sample. IS61 10 DNA was found in samples from all six patients with active pulmonary tuberculosis (seven of eight samples). It was also found in 15 of 18 patients with past tuberculosis (16 of 20 samples), five of nine tuberculosis contacts (five ofnine samples), and five of 54 patients with non-tuberculous lung disease (six of 56 samples) ( figure, table 2) . Thus IS61 10 DNA detection was a sensitive test for tuberculosis, but was not specific for active disease.
Detection of the 65kDa Ag DNA was also very sensitive, in that it was found in samples from four of four patients with active tuberculosis (four offive samples), four of four patients with past tuberculosis (five of eight samples) and four of four contacts (four of six samples). It was also present in samples from 14 of 42 patients with non-tuberculous lung disease (15 of 43 samples), suggesting lack of specificity.
The findings were similar when the results from each sample were compared (table 2). Both IS61 10 and 65kDa Ag DNA were found in over three quarters of the samples from patients with active tuberculosis, and in over half the samples from patients with past tuberculosis or from contacts of cases of tuberculosis. IS61 10 DNA was identified in six of 56 samples from patients with a lung disease other than tuberculosis, and 65kDa Ag DNA was identified in 15 of 43 samples from these patients. There was no difference in the yield of positive results when sputum, bronchoscopy trap, and bronchoalveolar lavage samples were compared.
Discussion
Many different mycobacterial genes have been proposed as targets for the detection of M tuberculosis in clinical samples.45 1-24 The optimal target DNA has yet to be defined and the relation between positive identification ofM tuberculosis DNA and clinical disease is unknown. We have compared the detection of two mycobacterial DNA sequences as a diagnostic test for tuberculosis and correlated the presence of these DNAs with clinically active or past exposure to tuberculosis.
The study makes two observations. Firstly, IS61 10 DNA detection had some advantages over 65kDa Ag detection in the diagnosis of tuberculosis. IS6110 DNA was detected in a smaller proportion of patients with diseases unrelated to tuberculosis than 65kDa Ag DNA. IS6110 was also technically easier to detect than 65kDa Ag. The second observation was the high detection rate of both IS6110 and 65kDa Ag DNA in samples from patients with past tuberculosis and contacts of cases of tuberculosis.
In this study,.both IS61 10 DNA and 65kDa Ag DNA were identified in most samples from patients with tuberculosis, past tuberculosis and contacts. We had anticipated that IS61 10 DNA detection would have been greater because unlike the 65kDa Ag DNA it is present as multiple repeats in the M tuberculosis genome.3 For any mycobacterium there are thus several IS61 10 sequences but only one 65kDa Ag DNA sequence available for amplification.
The ability to identify an organism through its DNA depends on the specificity of a particular sequence of DNA for a given organism and the specificity of the selected primers for a given DNA sequence. The primers we used were highly specific for each DNA sequence and were selected because they had been used by others. homology with a few DNA sequences from genes of organisms other than M tuberculosis. None of the genes from these organisms, however, had sequences with homology to the second member of the pair of primers. Thus, even if these other organisms had been present in the sample, their DNA sequence would not have been amplified as this amplification occurs only when both primers bind to the target sequence. Finally, the specificity was confirmed when the amplified products had the predicted size, indicating that these products contained the anticipated number of nucleic acid bases.
The presence of 65kDa Ag DNA in samples from up to a third of patients with a diagnosis unrelated to tuberculosis suggests that PCR amplification of 65kDa Ag DNA may have limited clinical use. Because the less sensitive detection system for 65kDa Ag yielded positive results and the more sensitive detection system for IS6 110 DNA negative results in samples from most of these patients the DNA containing 65kDa Ag probably did not originate from M tuberculosis. The DNA sequence of the 65kDa Ag shares homology with the DNA sequence of M leprae,' the common antigen of pseudomonas, and the groEL protein of Escherichia coli.2"27 The possibility that the PCR used in this study was amplifying DNA from other, non-tuberculous, mycobacteria in the lungs was reduced by probing with TB4, which bound with high affinity to M tuberculosis DNA only. The 65kDa Ag gene in M tuberculosis is thought to be identical in terms of amino acid sequence with the same gene in M africanum and M bovis BCG."8 Similarly, IS6110 DNA is also found in M bovis and M simiae but not in other mycobacterial species. 4 We cannot exclude the possibility that the positive findings with IS6110 or 65kDa Ag DNA were the result of infection by other members of this small family of M tuberculosis like mycobacteria.
The other technical advantage of using IS6110 detection to diagnose tuberculosis was that it was more rapid. Results were documented by ethidium bromide staining of amplified products on a gel without the need to confirm the nature ofthe band by Southern blotting and hybridisation with the 32p labelled IS3 oligodeoxynucleotide probe. As sequences similar to 65kDa Ag DNA are present in other mycobacteria, probing with 32p labelled TB4 was required to confirm that the amplifiedproduct of the 65kDa Ag was derived from M tuberculosis. This additional step also increased the sensitivity of the test. Amplified 65kDa Ag DNA from eight patients was not clearly visualised by ethidium bromide staining but was identified following "P probing with the TB4 oligonucleotide.
The detection of both IS6110 and 65kDa Ag DNA in samples from patients with past tuberculosis and contacts of patients with tuberculosis was unexpected and poses a difficulty if these tests are to be clinically useful. Technical factors are unlikely to account for this observation. Although contamination of reagents by target DNA is a common problem with PCR,'930 this was excluded in our experiments as the negative controls were consistently negative. The laboratory equipment was cleaned regularly and checked by the "wipe test."3' Initial concern that contamination of the bronchoscope might result in false positive results was unfounded as the incidence of false positive results in samples obtained at bronchoscopy was similar to that in sputum ( 
